Clinical Trial Update: Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM) [NA]

View source ↗

Summary

A clinical trial evaluating vericiguat for chest pain caused by coronary microvascular dysfunction, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Microvascular Dysfunction
• Stable Angina

Drugs mentioned

• Verquvo (vericiguat)

Snippet

Sponsor: The University of Hong Kong | Conditions: Chest Pain | NA | Status: RECRUITING